2021 is well underway and the bulls are in full force as the Canadian Securities exchange have approached 2-year highs as the CSE hit 1,039.94 and the S&P/TSX Venture Composite Index reached a high of 1,098.56 on February 19th, 2021. Today we will be going over four stocks we believe investors should keep on their radar for the month of March!
Universal PropTech (TSX-V: UPI) has seen some major growth lately, and the month of March is setting up to be quite the month for UPI! We first alerted investors to UPI in the middle of December in our article titled “Universal PropTech (TSX-V: UPI) On High Alert!”, and since then shares of UPI have soared 167% to hitting a high of $.75 cents on big news. If you aren’t following UPI yet, you’re going to want to put it on your high priority list!
Recently UPI made a remarkably interesting investment in a company called ISBRG Corp. and secured agency rights in the company’s SpotLight-19 Technology. Spotlight-19 is a non-invasive Covid-19 testing technology which utilizes light and artificial intelligence to detect Covid-19 within 20 seconds, which is by far the fastest testing tool. The CEO of UPI Chris Hazelton stated, “We have been committed to ensuring safe and healthy workspaces for our clients and facilitating the return of workers to workspaces in the face of the pandemic, and SpotLight-19© as a rapid, inexpensive and reusable testing platform to ensure safe work environments, could be a catalyst to opening global economies. Upon completion of trials and relevant governmental approvals, Universal PropTech expects that it will aggressively market SpotLight-19© products and supporting services to all governmental and education providers across Canada”. ISBRG Corp. is past the proof-of-concept stage and the funding which UPI has provided will enable ISBRG to undergo trials to determine specificity and sensitivity of SpotLight-19© under the authorization of Health Canada.
As of this morning, Universal PropTech announced that the company has received its German listing and today, UPI is available on the Frankfurt exchange under the ticker (FSE: 8LH). This new listing will broaden UPI’s investor base in the German market, and we believe a US listing on the OTC market will be coming very soon!
Many investors know that we have been long supporters of Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) and last week shares of Kontrol began to recover after the company experienced selling pressure associated to an attack from an unscrupulous group, questioning BioCloud and the management behind the technology. On February 22nd, 2021, KNR announced new additions to its scientific advisory board which consists of Caroline Duchaine, Ph.D. a full-time professor at the department of microbiology, biochemistry and bioinformatics at the University of Laval, David E. Heinrcihs, Ph.D, professor of Microbiology and Immunology at Western University, and Jimmy Dikeakos, Ph.D. an associate Professor at the Department of Microbiology and Immunology at Western University.
The VP of Kontrol Mr. Gary Saunders was quoted "Our advisory board members are at the top of their field and their counsel will be very important to the future of Kontrol BioCloud and other innovative applications of the technology we may seek to develop”. In addition to KNR adding great scientific members to its advisory board, Kontrol also announced that the company will be providing field demonstrations of BioCloud in real-time that are in operation by various customer and/or pilot customers. The CEO of KNR Mr. Paul Ghezzi was quoted "To the extent that we have customer approval we will also share operating data with respect to specific applications. Where we are unable to provide specific operating access to a customer application, we will seek to aggregate and showcase that data in a manner which meets any privacy constraints”.
There are still a lot of catalysts that we are on the look out for which includes possible updates from the United Arab Emirates, possible government sales with the Ontario government, uplisting to the TSX and Nasdaq.
Rritual SuperFoods is a new functional food company that will be IPO-ing this week and it is anticipated that the company will begin trading the first week of March on the Canadian Securities Exchange under the symbol (RSF). Rritual prides itself of providing the health and wellness industry with organically sourced superfoods under its very own brand called Rritual.
Rritual is entering an emerging sector within the health and wellness sector called superfoods or commonly referred to as “Nootropics”, and the company has assembled a robust management team with a strong background within the CPG industry. Rritual is currently selling its premium brand on its native website https://rritual.com, and an aggressive push towards established brick and mortar brands is expected in 2021 in both the United States and Canada!
This week we will be issuing more insight into the upcoming IPO of Rritual Superfoods Inc., and why investors will want to put Rritual Superfoods on their radar once it goes public later this week!
We first wrote about Taat Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) in our article titled “Stocks To Watch in November”. Since we featured TAAT, Shares of TAAT have rallied 160% hitting an all-time high of $6.00 from our alert of $2.30!
Since then, TAAT has launched its Beyond Tobacco, a tobacco-free product derived from hemp in the state of Ohio, and most recently, TAAT has launched online sales. On February 22nd, 2021, TAAT announced that the company achieved sales of over CAD $100,000 through its online store. The CEO of TAAT Mr. Setti Coscarella stated “To sell more than CAD $100,000 worth of a relatively new product in such a short period is absolutely exceptional. Countless smokers aged 21+ in the United States have been eagerly awaiting the launch of our online store on Wednesday, which I believe has contributed significantly to our product sales this past week”.
Last week, TAAT announced that the company entered into a memorandum of understanding (“MOU”) with Christina Lake Cannabis Corp (CSE: CLC) to expand and distribute the TAAT tobacco free product for the Canadian market. Under the agreement, Christina Lake will utilize its status as a Licensed Producer in the Cannabis Act in Canada to secure hemp biomass from third-party cultivators to manufacture TAAT’s Beyond Tobacco for Canadian consumers. In the US, TAAT’s tobacco free cigarettes are priced fairly low at USD $3.99 per pack and if TAAT’s tobacco free cigarettes are priced below the average of Canadian cigarettes between $15 and $20 per pack, we believe the TAAT brand will be well received and sales could do well.
Forward Looking Statements: This article may contain "forward-looking information" (as defined in applicable Canadian securities legislation) that is based on expectations, estimates and projections as of the date of the content is published on this website. Wherever possible, words such as "anticipate", "believe", "expects", "intend" and similar expressions have been used to identify these forward- looking statements. Information in this article has been furnished for your information only, is accurate at the time of posting, and may be superseded by more current information. Except as required by law, we do not undertake any obligation to update the information, whether as a result of new information, future events or otherwise. This article should not be considered as personal financial advice. Full Disclosure: Universal PropTech Inc. and Rritual Superfoods Inc, are clients of The parent company of EquityInsight.ca. Directors of the parent company of Equity Insight may buy, hold or sell the securities before during or after this publication.